The Latest: WH nixes FDA guidelines on vaccine approval | World

South Korea has reported slightly more than 400 deaths from the coronavirus, while Japan has confirmed about 1,600.

Japan has imposed an entry ban on people from many countries because of the pandemic. The ban has been gradually relaxed, including for travelers from Thailand, Singapore and Vietnam, although a 14-day quarantine is required.

NEW DELHI — India has registered 61,267 new coronavirus cases, its lowest daily increase since Aug. 25.

The country with nearly 6.7 million reported infections has had the highest single-day increases in the world for nearly 45 days. The last three weeks, however, have seen a gradual decline.

The Health Ministry on Tuesday also reported 884 deaths in the past 24 hours. The death toll now stands at 103,569.

India has the second-highest number of reported infections and is on track to exceed the caseload in the United States within weeks.

COLOMBO, Sri Lanka — Sri Lanka

Read More

Trump misinformation; Moderna vaccine; SNL; Fauci masks


Here are three ways consumers can help support small businesses who are struggling financially during the coronavirus pandemic.


Despite President Donald Trump repeatedly assuring the nation that a coronavirus vaccine would be approved before Election Day, a key vaccine developer said Thursday its product won’t be released to the public until March 2021 at the earliest. 

Meanwhile, Dr. Anthony Fauci rebutted some of the president’s claims during Tuesday’s debate with former vice president Joe Biden, telling ABC News his views on masks were “taken out of context.”

A new study out of Cornell found that Trump is the “single largest” transmitter of misinformation surrounding COVID-19, touting false “miracle cures” and giving credence to dubious claims about the origins of the virus. 

“Saturday Night Live,” which is set to come back this week, may be in some hot water with the state of New York. The show’s producers announced

Read More

Trials For Russian Coronavirus Vaccine May Begin in India in Upcoming Weeks

a man wearing a blue hat

© Ritu Singh | News Desk

New Delhi: With Russia’s latest tie-up with Dr Reddy Laboratories Ltd, the final stage clinical trials of the world’s first potential coronavirus vaccine – Sputnik V – could begin in India in the next few weeks. The COVID antidote, that has been developed by Russian Direct Investment Fund, is set to enroll at least 1,000 to 1,200 participants for the late-stage trials at multiple government and private hospitals across the country, officials at the drugmaker firm said. “We want to get to the first step – which is the commencement of the clinical trials by getting the necessary approvals from the Indian regulators – within the next few weeks,” Deepak Sapra, CEO for API and pharmaceutical services at Dr Reddy’s told Reuters. Notably, once approved, Russia is expected to supply 100 million doses of the coronavirus vaccine to India. Deliveries could potentially
Read More

The Latest: US company moves virus vaccine study to UK

GAITHERSBURG, Md. — A U.S. biotechnology company is moving its experimental COVID-19 vaccine into final-stage testing in Britain, a different kind of shot than other leading candidates.

Novavax Inc. announced Thursday that the Phase 3 study getting underway in the United Kingdom aims to test up to 10,000 volunteers, at least a quarter of them over age 65.

In mid-October, the company is set to begin another, much bigger final study in the U.S. that will recruit 30,000 people.

The Novavax shot is what’s called a recombinant vaccine, made with lab-grown copies of the “spike” protein that studs the surface of the coronavirus. Study participants will receive two doses of vaccine or a dummy shot.



— Russia reports highest daily cases since July

— India reports another 86,508 new coronavirus cases

— UK to subsidize wages of pandemic-idled workers

Read More